Our university closes anti-cancer drug development technology transfer contract with bio company
- Views 716
- Writer 커뮤니케이션팀
- 보도일자 2015-10-12
The research team led by Professor Yoon developed a bio big data analysis system, which is the core of the technology being transferred, and a platform that integrates this with siRNA screening technology. This research is the result of five years of development from 2011, based on support from the Ministry of Science, ICT and Future Planning for basic research business and bio medical technology development.
Professor Suk-joon Yoon of the Department of Biological Science (photograph, right) and CEO Ki-youn Nam of Qurient Co., Ltd. are taking a photograph to celebrate the closing of the technology transfer contract.
Professor Yoon’s team and the Industry-Academia Cooperation Group received E-TLO support from the Ministry of Science, ICT and Future Planning in July through the TLO capacity strengthening support business, to participate in the ‘Inter-Biz Bio & Investment Partnering Forum,’ which is the biggest bio investment and partnering forum in Korea. They actively promoted their technology to around twenty domestic pharmaceutical companies there, and continued active search and promotions for technology transfer, and ended up closing the technology transfer contract with Qurient.
Professor Yoon revealed his determination, saying, “We will secure global competitiveness for development of customized anti-cancer drugs and methods of clinical test applications, and pursue follow-up businesses with domestic and international new anti-cancer drug development companies,” and stressed, “Application of this technology will accelerate development of anti-cancer drugs customized according to patient gene type.” CEO Ki-youn Nam of Qurient said, “We will use the platform technology for development of anti-cancer drugs provided by Sookmyung Women’s University to purse development of anti-cancer drugs customized for patients, and excavate a new anti-cancer target for clinical applications in the near future.”
Choong-il Chun, head of the Industry-Academia Cooperation Center, said, “This technology transfer will be a turning point for us to expand out excellent technology business to the industry, and accelerate a good cycle where this is then turned into a basis for following studies,” and added, “We also plan to establish a success model for technology commercialization of universities in connection with the university asset commercialization projects of the Ministry of Science, ICT and Future Planing, and the Ministry of Education (The TLO Capacity Strengthening Support Business of the Ministry of Science, ICT and Future Planning, and the Creative Asset Commercialization Support Business of the Ministry of Education).”